Mark S Todtenkopf
7PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 25, 2024
Opioid antagonists: clinical utility, pharmacology, safety, and tolerability.Roger S McIntyre, Marni E Harris, Mark S Todtenkopf
|Oct 20, 2023
Comment on "Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review".Mark S Todtenkopf, Christoph U Correll, Marni E Harris-White
|Mar 03, 2022
Opioid antagonism mitigates antipsychotic-associated weight gain: focus on olanzapine.Roger S McIntyre, Leslie Citrome, Hannah Cummings
|Sep 16, 2021
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder.Leslie Citrome, Christine Graham, Adam Simmons
|Oct 01, 2019
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future.Leslie Citrome, Joseph P McEvoy, Mark S Todtenkopf
|Sep 07, 2018
Evaluation of samidorphan, a μ-opioid antagonist, in a drug discrimination assay in rats.Mario P Sgro, Deah L Modlin, Daniel R Deaver
Pageof 2
Frequent Collaborators
3 joint publications
Leslie Citrome
2 joint publications
Roger S McIntyre
1 joint publications
Peter J Weiden
1 joint publications
Bernard Silverman
1 joint publications
Lei Sun
1 joint publications
Sarah Akerman
1 joint publications
Christoph U Correll
1 joint publications
Marni E Harris-White
1 joint publications
Michael J Doane
1 joint publications
David McDonnell
